Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromhexine Hydrochloride Solution for Inhalation in Lower Respiratory Tract Infection with Viscous Sputum
CTR20231071Phase 3Completed
- Sponsor
- Sinopharm Holding Anhui Nuohua Pharmaceutical
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bromhexine in acute bronchitis, chronic bronchitis (CB), chronic obstructive pulmonary disease (COPD), pneumonia, sponsored by Sinopharm Holding Anhui Nuohua Pharmaceutical. Started Apr 2023; status: completed.
02
Drugs
bromhexine
03
Conditions
acute bronchitischronic bronchitis (CB)chronic obstructive pulmonary disease (COPD)pneumonia
Beyond the preview
Go deeper on CTR20231071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231071.